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Abstract
Lung cancer is a leading cause of cancer-related death in the world. Smoking is definitely the most important risk
factor for lung cancer. Radon (222Rn) is a natural gas produced from radium (226Ra) in the decay series of uranium
(238U). Radon exposure is the second most common cause of lung cancer and the first risk factor for lung cancer in
never-smokers.
Case–control studies have provided epidemiological evidence of the causative relationship between indoor radon
exposure and lung cancer. Twenty-four case–control study papers were found by our search strategy from the
PubMed database. Among them, seven studies showed that indoor radon has a statistically significant association
with lung cancer. The studies performed in radon-prone areas showed a more positive association between radon
and lung cancer. Reviewed papers had inconsistent results on the dose–response relationship between indoor
radon and lung cancer risk.
Further refined case–control studies will be required to evaluate the relationship between radon and lung cancer.
Sufficient study sample size, proper interview methods, valid and precise indoor radon measurement, wide range of
indoor radon, and appropriate control of confounders such as smoking status should be considered in further
case–control studies.
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Background
Lung cancer is a leading cause of cancer-related death in
the world. Smoking is definitely the most important risk
factor for lung cancer. Environmental and occupational
exposure to carcinogens such as asbestos, radon, poly-
cyclic aromatic hydrocarbons, and metals including
nickel, arsenic, and chromium is also an important risk
factor for lung cancer.
Radon (222Rn) is an inert gas produced naturally from
radium (226Ra) in the decay series of uranium (238U).
Radon gas is an important source of ionizing radiation,
and it decays with a half-life of 3.8 days. Radon emanates
from rocks, soils, and groundwater. It can damage the
DNA of the respiratory epithelium, and exposure to
radon is assumed to be the cause of lung cancer [1].
In 1988, the International Agency for Research on
Cancer declared that radon is an important cause of
lung cancer [2]. Radon exposure is strongly related to
small cell carcinoma and squamous cell carcinoma of
the lung [3–6]. Radon exposure is the second most com-
mon cause of lung cancer and the first risk factor for
lung cancer in never-smokers [7].
Early studies on radon as a risk factor for lung cancer
focused on occupational exposure such as in underground
miners [8–12]. These studies established the increased risk
of lung cancer for both smokers and non-smokers. After
that, research on the relationship of indoor radon and
lung cancer in the general population was conducted.
The main epidemiological evidence is from cohort
studies or case–control studies. The cohort studies have
a limited role in assessment for radon as a risk factor for
lung cancer due to the relatively low incidence of lung
cancer in the general population. To overcome the limi-
tations of cohort studies, case–control studies play an
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important role in the assessment of the causative rela-
tionship between indoor radon exposure and lung
cancer.
This review focuses on the case–control studies on the
risk of lung cancer from indoor radon exposure in the
general population. We intend to propose a desirable de-
sign of case–control studies on indoor radon and lung
cancer risk for the general population in future studies.
Literature search
We performed searches for case–control studies about
indoor radon exposure and lung cancer risk. The prede-
fined keywords (indoor or residential; radon; case con-
trol; lung cancer) were used for search. The searches for
the studies found 143 results through PubMed database.
There were no language or time period limitations (up to
31st December 2015) during initial search. The identified
studies were screened by two researchers independently.
The studies other than case–control study excluded from
this review. The language (English full-text) and size cri-
teria (more than 100 case and 100 controls) restriction
were adopted. Finally, 24 papers fulfilled the inclusion cri-
teria. All of studies performed indoor air radon concentra-
tion measurements (Fig. 1).
Case–control studies that included both smokers and
never-smokers
Twenty studies that included both smokers and never-
smokers were conducted (Table 1). There were incon-
sistencies in the study results from study to study on the
relation between indoor radon and lung cancer risk.
Sixteen studies showed an estimated odds ratio of 1 or
more. Among them six studies showed statistically
significant results.
The largest scale case–control study was a German
study published in 2005. Wichmann et al. included study
subjects aged 24 to 75 years comprising 2,963 cases and
4,232 controls [13]. The exposures to indoor radon were
categorized into four groups with cut-off points at 50,
80, and 140 Bq/m3. The odds ratio (OR) for the category
with indoor radon concentration between 80 and
140 Bq/m3 was 1.06 (95 % CI: 0.87–1.30), and the OR
for the group with indoor radon concentration above
140 Bq/m3 was 1.40 (95 % CI: 1.03–1.89) compared to
the category with the lower exposure (<50 Bq/m3). The
level of 140 Bq/m3 is a meaningful radon concentration,
as it is close to 148 Bq/m3, the EPA action level for
radon in homes [7]. The risk for small cell carcinoma
was higher than that for other histologies of lung cancer.
This study showed a linear dose–response relationship
between radon exposure and lung cancer in both
smokers and never-smokers. The overall excess OR
(EOR) of lung cancer per 100 Bq/m3 was 0.10 (95 % CI:
−0.02–0.30). The EOR of lung cancer per 100 Bq/m3
was 0.14 (95 % CI: −0.06–0.52) in current smokers and
0.07 (95 % CI: −0.15–0.80) in never-smokers. This result
suggests that the linear dose–response relation between
radon exposure and lung cancer is more apparent in
smokers than in never-smokers.
In 1990, Shoenberg et al. published a report on the
strong association between indoor radon exposure and
lung cancer risk [14]. This study was conducted in New
Jersey, United States. They studied 433 female lung can-
cer cases and 402 controls. Both smokers and never-
smokers were included in this study. Study subjects lived
in the same house for at least 10 years to allow sufficient
duration of indoor radon exposure. The OR of the cat-
egory with the highest radon exposure (>148 Bq/m3)
was 4.2 (95 % CI: 0.99–17.5) compared to the category
with the lowest radon exposure (≤37 Bq/m3). Large cell
undifferentiated carcinomas (p = 0.27) had a pattern of
increasing risk with increasing radon concentration. This
study reported stronger evidence of the lung cancer risk
caused by indoor radon compared to other case–control
studies. However, separate analyses for never-smokers
failed to show the relation between radon exposure and
lung cancer risk. There were 61 lung cancer cases of
never-smokers in this study. Only two cases and six con-
trols were never-smoking subjects exposed to the high-
est radon concentration. The possibility of inaccuracies
in the exposure estimates, selection biases, and the small
number of never-smoking subjects with high radon ex-
posures should be noted in this data interpretation.
Some studies showed weak or non-significant evidence
of the association between indoor radon exposure and
Fig. 1 Flowchart for inclusion and exclusion
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Table 1 Case–control studies for radon and lung cancer in smokers and never-smokers



















Blot et al. 1990 China Female 308 356 0.7 (0.4–1.3) 85 2 bedroom, living room 12 study subjects, proxy
Schoenberg et al. 1990 United States Female 433 402 4.2 (0.99–17.5) NAb 2 bedroom, basement 12 study subjects, proxy
Pershagen et al. 1992 Sweden Female 210 209 1.7 (1–2.4) 128 2 bedroom, living room 3 study subjects, proxy
Létourneau et al. 1994 Canada Both 738 738 0.77 (0.34–1.73) 120 2 bedroom, basement 12 study subjects, proxy
Pershagen et al. 1994 Sweden Both 1360 2847 1.8 (1.1–2.9) 107 2 bedroom, living room 3 study subjects, proxy
Auvinen et al. 1996 Finland Both 517 517 1.15 (0.69–1.93) 103 96 1 bedroom or living room 12 study subjects, proxy
Ruosteenoja et al. 1996 Finland Male 291 495 1.5 (0.8–2.9) 213 1 living room or bedroom 12 study subjects, proxy
Darby et al. 1998 United Kingdom Both 960 3126 1.79 (0.74–4.33) 58 56 2 bedroom, living room 6 study subjects
Alavanja et al. 1999 United States Female 247 299 0.71 (0.3–1.3) 57 60 2 bedroom, kitchen 12 study subjects, proxy
Field et al. 2000 United States Female 413 614 1.79 (0.99–3.26) 100 89 3 basement, first floor, second floor 12 study subjects
Pisa et al. 2001 Italy Both 138 291 1.0 (0.3–3.1) NA 1 bedroom 12 study subjects, proxy
Barros-Dios et al. 2002 Spain Both 163 241 2.96 (1.29–6.79) 75 66 1 bedroom 3 study subjects, proxy
Wang et al. 2002 China Both 768 1659 1.58 (1.1–2.3) 230 222 2 bedroom, living room 12 study subjects, proxy
Baysson et al. 2004 France Both 486 984 1.11 (0.59–2.09) 83 80 2 bedroom, living room 6 study subjects
Bochicchio et al. 2005 Italy Both 384 405 2.89 (0.45–18.6) 113 102 2 bedroom, living room 6 study subjects
Wichmann et al. 2005 Germany Both 2963 4232 1.4 (1.03–1.89) 61 60 2 bedroom, living room 12 study subjects
Sandler et al. 2006 United States Both 1474 1911 1.00 (0.93–1.07) 40 45 2 bedroom, lowest living level 12 study subjects
Thompson et al. 2008 United States Both 200 397 2.5 (0.47–13.46) 68 66 2 bedroom, living room 12 study subjects, proxy
Wilcox et al. 2008 United States Both 561 740 0.76 (0.36–1.61) 46 46 1 living room 12 study subjects, proxy
Barros-Dios et al. 2012 Spain Both 349 513 2.21 (1.33–3.69) NA 1 unclear 3–6 study subjects

















lung cancer. In 2008, Wilcox et al. reported the results
of a case–control study on radon and lung cancer in
New Jersey, United States [4]. A total of 651 lung cancer
cases and 740 controls contributed to the analysis of
radon exposure and the risk of lung cancer. There were
only 40 (6.1 %) never-smokers in the lung cancer cases
and 116 (16 %) never-smokers in the controls. Indoor
radon exposures were divided into six categories (≤25,
25–49, 50–74, 75–99, 100–149, and ≥150 Bq/m3). The
authors failed to show a statistically significant relation
between indoor radon exposure and lung cancer risk.
However, the ORs showed a tendency to increase with
elevated radon exposure up to the 100–149 Bq/m3 cat-
egory. Although the EOR per 100 Bq/m3 was −0.13
(95 % CI: −0.14–0.56) for males and 0.29 (95 % CI:
−0.12–1.70) for females, this study showed radon expos-
ure slightly increased the risk of lung cancer (overall
EOR = 0.05 per 100 Bq/m3, 95 % CI: −0.14–0.56).
The highest exposure category (≥150 Bq/m3) had few
cases, and the ORs were smaller (OR 0.76, 95 % CI:
0.36–1.61) than those in the lower exposure categories.
The results of this study seem to suggest a nonsignifi-
cant small effect of residential radon exposure on the
risk of lung cancer. However, this study may underesti-
mate the true exposure–response relationship due to
selection bias among heavy smokers, influence for infor-
mation by proxy interviews, and uncertainties regarding
radon measurements.
In Asia, two case–control studies met our searching
conditions. Both studies were conducted in China. These
Chinese studies also showed inconsistent results on in-
door radon and lung cancer risk.
In 1990, Blot et al. reported that there was no differ-
ence in indoor radon levels between lung cancer cases
and controls [15]. This study included 308 lung cancer
cases and 356 controls, and all study subjects were
women. The OR of the category with the highest radon
exposure (>296 Bq/m3) was 0.7 (95 % CI: 0.4–1.3)
compared to the category with the lowest radon expos-
ure (<74 Bq/m3). They also reported that lung cancer
risk did not increase with increasing radon levels in
homes in Shenyang City.
Contrary to the results of Blot et al., Wang et al.
(2002) published a case–control study conducted in
Gansu Province, China [16]. Gansu Province is a rural
area with high radon levels and low mobility of resi-
dents. The OR of the category with the highest radon
exposure (>300 Bq/m3) was 1.58 (95 % CI: 1.1–2.3) com-
pared to the category with the lowest radon exposure
(<100 Bq/m3). The EORs for indoor radon concentration
of 100 Bq/m3 were 0.14 (95 % CI: −0.03–0.54), and this
result showed that lung cancer risk increased with in-
creasing indoor radon concentrations. The overall re-
sults of this study showed that high levels of indoor
radon exposure increased the lung cancer risk. However,
never-smokers were only 5 % of cancer cases and 8.9 %
of controls in the male subjects in this study. The type
of residence was an underground dwelling in more than
half of both lung cancer cases and controls, and this pat-
tern of residence is different from other studies.
Case–control studies that included non-smokers only
Case–control studies that include non-smokers only are
very important for the estimation of the indoor radon and
lung cancer association, because the effect of smoking, the
largest confounder, can be minimized. There were only
four studies on indoor radon exposure and lung cancer in
non-smokers (Table 2) [17–20]. Two studies included only
female non-smokers, and the other two studies included
both male and female non-smokers.
Lagarde et al. (2001) published the results of their
study, which included 258 never-smoking lung cancer
cases and 487 never-smoking controls [18]. Both males
and females were included in the study. The mean pe-
riods of residence in radon-measured homes were
26.1 years among cases and 26.8 years among controls.
Table 2 Case–control studies for radon and lung cancer in non-smokers











































Spain Both 192 329 2.42 (1.45-4.06) NA 1 bedroom 3 study subjects
aThe highest exposure versus. the lowest exposure of radon
bNot applicable
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The OR of the category with the highest radon exposure
(>140 Bq/m3) was 1.55 (95 % CI: 0.88–2.73) compared to
the category with the lowest radon exposure (≤50 Bq/m3).
This study showed a dose–response effect of radon on
lung cancer (overall ERR per 100 Bq/m3 = 0.28 (CI: −0.05-
1.05)). The ERRs for the indoor radon concentration of
100 Bq/m3 were 0.02 (95 % CI: −0.06–0.32) in subjects
not exposed to environmental tobacco smoke at home
and 0.29 (95 % CI: −0.03–1.24) in subjects exposed to en-
vironmental tobacco smoke at home. These results also
might suggest an effect of indoor radon exposure and en-
vironmental tobacco smoke on the risk of lung cancer.
Torres-Durán et al. (2014) studied 192 lung cancer
cases and 329 controls in Galicia, Spain [17]. Study sub-
jects were male or female never-smokers aged over
30 years. Adenocarcinoma was the most common histo-
logic type of lung cancer (77.5 %) in this study. The median
number of years living in the radon-measured home was
over 30 years for both cases and controls. Indoor radon ex-
posures were divided into four categories according to the
level of radon measured (≤100, 101–147, 148–199, and
≥200 Bq/m3). This study showed a significant relation be-
tween indoor radon and lung cancer. The OR of the highest
radon-exposed individuals (>200 Bq/m3) was 2.42 (95 % CI:
1.45–4.06) compared to the lowest radon-exposed group
(<100 Bq/m3). In addition, individuals who had been ex-
posed to >200 Bq/m3 and who had not lived with a smoker
showed a significant OR of 1.99 (95 % CI: 1.16–3.41).
Moreover, these results suggest an effect of indoor radon
exposure and environmental tobacco smoke on the risk of
lung cancer. However, this study could not evaluate the re-
lation between radon and lung cancer subtype, because
there were only 43 (22.5 %) subjects with histologic types of
lung cancer other than adenocarcinoma.
However, a German case–control study by Kreuzer et al.
(2002) failed to show a link between indoor radon and
lung cancer risk in non-smoking women [19]. They de-
fined non-smoking women as having smoked less than
200 cigarettes in a lifetime. This study included 234 lung
cancer cases and 535 controls. Measurements of one-year
radon concentrations in the last dwelling were performed.
The median concentrations of indoor radon did not differ
between lung cancer cases (45 Bq/m3) and controls
(44 Bq/m3). There was no significant trend in lung cancer
risk with increasing indoor radon levels (p = 0.22). How-
ever, 42 % of cancer cases and 16 % of controls were ex-
cluded from analysis due to missing radon measurements
in this study.
Alavanja et al. (1994) published their study that in-
cluded never-smokers and former smokers [20]. This
study was carried out in Missouri, United States. Former
smokers were defined as women who ceased using to-
bacco 15 or more years prior to the interview. Radon ex-
posures were divided into five categories by quintile
interval (0.1–0.79, 0.80–1.19, 1.20–1.69, 1.70–2.45,
2.46–15.3 pCi/L). The relative risk of lung cancer for
women exposed to the highest radon concentrations
was 1.20 (95 % CI: 0.7–1.7) compared with the women
exposed to the lowest radon concentrations. A positive
dose–response relation was suggested for adenocarcin-
oma among directly interviewed women (p = 0.04 cat-
egorical data analysis). However, the relative risk for the
highest decile of radon exposure was below 1.0 com-
pared with the lowest decile. An association between in-
door radon and lung cancer risk was not convincingly
demonstrated in this study. However, proxy interviews
were conducted in 341 cases (63 %). There was a limited
range of radon concentrations, because Missouri is an
area with relatively lower radon exposure. The cut-off
point of the highest radon exposure category was only
91 Bq/m3, and this was the lowest cut-off point of the
highest radon exposure category except for the study by
Sandler et al. (2006) (53 Bq/m3) [21]. These limitations
could have influenced the results of this study.
Studies in radon-prone areas versus lower exposure areas
The studies in radon-prone areas had a tendency to
show an association between radon and lung cancer risk.
However, the studies that failed to show a relation be-
tween indoor radon exposure and lung cancer risk were
usually conducted in areas with relatively lower radon
exposure.
Blot et al. (1990) conducted a case–control study in
the northern industrial city of Shenyang, and this city is
an area with lower radon exposure in China [15]. Their
results failed to show a relation between indoor radon
and lung cancer. Another Chinese study by Wang et al.
(2002) was carried out in Gansu Province, a rural area
with high radon levels [16]. This study provided evi-
dence that high levels of residential radon increase the
risk of lung cancer. According to the results from Wang
et al., the mean indoor radon concentrations for cases
and controls were 230.4 and 222.2 Bq/m3, respectively,
and these radon levels were much higher than the re-
sults from Blot et al. (85 Bq/m3).
A German study by Kreuzer et al. (2002) and American
studies by Alavanja et al. (1994) and by Sandler et al. (2006)
were conducted in areas with lower radon exposure, and
these studies also failed to show an association between in-
door radon exposure and lung cancer risk [19, 21].
Sandler et al. divided indoor radon exposures into four
categories by quartiles of radon exposure. The cut-off
points for the highest and lowest quartiles of indoor
radon concentrations were only 53 and 18 Bq/m3, re-
spectively, and these cut-off points were lower than
those of all other studies. This study was conducted in
Connecticut and Utah, areas with lower radon exposure
in the United States, and this could be one of the main
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reasons it failed to show a relation between indoor radon
and lung cancer.
Contrary to the results by Sandler et al., a case–con-
trol study (Field et al., 2000) conducted in Iowa, a
radon-prone area in the United States, showed signifi-
cant results for radon and lung cancer risk [22].
Recent case–control studies have shown strong effects
of indoor radon exposure on lung cancer except for two
studies (Sandler et al. 2006, Wilcox et al. 2008) in the
United States [4, 21].
Spanish studies in 2012 and 2014 were carried out in a
radon-prone area (Galicia) [17, 23]. About 20 % of all
dwellings were above the EPA action level for indoor
radon, because the ground in Galicia contains high levels
of granite [7]. These studies showed significant evidence
of the link between indoor radon and lung cancer risk.
Radon exposure occurs both indoors and outdoors. In-
door radon exposure is higher in radon-prone areas than
in lower radon exposure areas. Additional radon expos-
ure from the environment rather than indoor radon is
much higher in radon-prone areas than in lower radon
exposure areas. Thus, even if we consider different levels
of indoor radon between radon-prone areas and lower
radon exposure areas, dwellers in radon-prone areas are
actually exposed to much larger amounts of radon than
those in lower radon exposure areas due to the accumu-
lation of indoor and outdoor radon exposure. The
threshold dose of radon for a carcinogenic effect could
be more easily accumulated and shorter periods could
be required for radon to become a carcinogenic hazard
in radon-prone areas. In addition, studies in radon-
prone areas might have an advantage for the evaluation
of the dose–response relationship of indoor radon and
lung cancer risk, because the radon exposure range is
wider than in lower radon exposure areas. Therefore,
this geological characteristic could have advantages in
analyzing the radon effect on lung cancer risk.
A dose–response relationship between indoor radon and
lung cancer
Nine reports showed evidence that lung cancer risk in-
creases with increasing indoor radon concentration
(Table 3).
The lung cancer risk increases from 4 (Baysson et al.
2004) to 28 % (Lagarde et al. 2001) with increasing
radon levels per 100 Bq/m3 in overall subjects. The lung
cancer risk increases from 2 to 80 % with increasing
radon levels per 100 Bq/m3 in smokers.
Darby et al. (1998) is the only study that did not show a
positive dose–response relationship between radon and
lung cancer in a subgroup analysis for smokers, although
there were positive dose–response relationships between
radon and lung cancer in both the non-smoker and ex-
smoker subgroups. The authors stated that this study was
carried out in Devon and Cornwall, South-west England,
which is a radon-prone area in the United Kingdom. How-
ever, measured mean concentrations of indoor radon
(cases 58 Bq/m3, controls 56 Bq/m3) were lower than
those in the previous database in this area. Moreover,
these concentrations were not significantly higher levels of
indoor radon compared with other studies. The possibility
that the study was actually conducted in a lower radon ex-
posure area or that the radon measurements were under-
estimated should be considered.
The lung cancer risk increased from 4 to 28 % with in-
creasing radon levels per 100 Bq/m3 in the subgroup
analysis for never-smokers. Bochicchio et al. (2005)
failed to show a positive dose–response relationship be-
tween indoor radon and lung cancer risk in never-
smokers.
The results of the linear dose–response relationship
between radon and lung cancer from smokers were
much higher than the results from ex-smokers and non-
smokers, and these suggest that indoor radon exposure
has the strongest effects on lung cancer in smokers.
Among the studies that included only never-smokers
as study subjects, only one study by Lagarde et al. (2001)
showed a linear relationship between radon exposure
and lung cancer risk [18]. The overall ERR of this study
was the highest (ERR = 0.28, 95 % CI: −0.05–1.05) com-
pared to the results from other studies. The ERR was
much higher in subjects with environmental tobacco
smoking exposure than in subjects without environmen-
tal tobacco smoking exposure. This result shows that ex-
posure to environmental tobacco smoking at home also
has strong effects on the effect of indoor radon exposure
on lung cancer risk.
Previous studies on radon and lung cancer in miners
showed a linear dose–response relationship for lung can-
cer risk and mortality [24, 25]. A European collaborative
analysis study of the general population included 7,148
lung cancer cases and 14,208 controls and was published
by Darby et al. in 2006 [26]. This study reported that the
linear dose–response relationship remained significant
with no evidence of a threshold when only individuals
with radon concentrations of < 200 Bq/m3 were in-
cluded. A recent meta-analysis on this issue reported
evidence of a nonlinear dose–response relationship be-
tween radon exposure and the risk of lung cancer [27].
Duan et al. (2015) concluded that there is a non-linear
dose–response relationship between indoor radon and
lung cancer risk, but according to the results, a linear
dose–response relationship was obvious in the individ-
uals exposed to less than 200 Bq/m3 of radon, but this
incremental relationship was weak in individuals ex-
posed to more than 200 Bq/m3 of radon. However, the
heterogeneity of these studies causes some limitations in
data interpretation.
Sheen et al. Annals of Occupational and Environmental Medicine  (2016) 28:9 Page 6 of 9
There were no consistent results on the dose–response
relationship between indoor radon and lung cancer risk.
As the dose of exposure for indoor radon is relatively
smaller than that for miners, it is difficult to evaluate the
dose–response effect of indoor radon on lung cancer
risk. Further studies are needed to evaluate the dose–re-
sponse relationship between indoor radon and lung
cancer risk.
Radon and lung cancer risk of histologic subtype
Shoenberg et al. (1990) showed a strong association be-
tween indoor radon exposure and lung cancer risk [14].
This study reported that large cell undifferentiated car-
cinomas (p = 0.27) have a pattern of increasing risk
with increasing radon concentrations. The study by
Alavanja et al. (1994) that included never-smokers and
former smokers showed a positive dose–response rela-
tion for adenocarcinoma among directly interviewed
women (p = 0.04 categorical data analysis) [20]. The
risk for small cell carcinoma was significantly elevated
(EOR = 0.29 CI: 0.04–0.78) in the study by Wichmann
et al. (2005). Wilcox et al. (2008) failed to show a sta-
tistically significant relation between indoor radon
exposure and overall lung cancer risk [4]. However, the
authors showed that radon exposure had a strong ef-
fect on small cell lung cancer in cases of both genders,
but the causative relation of indoor radon and squamous
cell carcinoma was only demonstrated in male cases.
Previous studies have showed evidence that indoor radon
exposure is strongly related to small cell carcinoma and
squamous cell carcinoma of the lung [28, 29]. The studies
that only included never-smokers were very limited and
produced inconsistent data for radon and adenocarcinoma
of the lung [6, 30]. Further evaluation of the causative rela-
tion of indoor radon and subtypes of lung cancer, especially
adenocarcinoma, is required.
Future study design
Smoking is the leading cause of lung cancer. To max-
imally control the strong effects of smoking on lung
cancer, a substantial number of never-smokers should be
included in future studies. Chronic radon exposure is re-
quired to cause lung cancer in the general population.
The induction duration of lung cancer due to radon ex-
posure is usually from 5 to 25 years [31]. However,
measuring indoor radon for this long is practically
impossible, so we need to estimate indoor radon concen-
trations exactly over these periods using radon measure-
ment with time-weighted averages for relatively short
durations. However, the indoor radon concentrations of
the same house can vary with the house’s ventilation pat-
tern, the season, and the year [32]. It is more reasonable
to measure indoor radon concentrations for a yearlong
period than for a season or a shorter period of a year. If
possible, repetition of a yearlong measurement of indoor
radon is recommended. Urban residents are more
mobile than rural residents. Thus, a single measurement
of indoor radon for the last dwelling may be inappropri-
ate. Indoor radon measurements must not be localized
in the house, but further measurements must be consid-
ered in the workplace and on public transportation such
as subways.
Table 3 Dose–response effects of radon for lung cancer
Author/year Nation EORa/ERRb per 100 Bq/m3 (95 % CI) radon concentration
Overall Smokers Ex-smokers Non-smokers
Pershagen et al. 1994 Sweden 0.10 (0.01–0.22) 0.14 (−0.06–0.52) NA 0.07 (−0.15–0.80)
Darby et al. 1998 United Kingdom 0.12 (−0.05–0.33) −0.04 (−0.22–0.14) 0.19 (0.03–0.35) 0.04 (−0.49–0.57)
Field et al. 2000 United States 0.24 (−0.05–0.92) NAc NA NA
Lagarde et al.d 2001 Sweden 0.28 (−0.05–1.05) 0.02 (−0.06–0.32) not exposed to ETSe at home
0.29 (−0.03–1.24) exposed to ETS at home
Wang et al. 2002 China 0.19 (−0.05–0.47) I:0.34/II:0.02/III:0.80f 0.09
Baysson et al. 2004 France 0.04 (−0.01–0.11) NA NA NA
Bochicchio et al. 2005 Italy 0.14 (−0.11–0.46) 0.16 (−0.12–0.51)g -0.23 (−0.64–0.66)
Wichmann et al. 2005 Germany 0.10 (−0.02–0.30) 0.14 (−0.06–0.52) 0.07 (−0.03–0.42) 0.07 (−0.15–0.80)
Wilcox et al. 2007 United States 0.05 (−0.14–0.44) Male: −0.13 (CI: −0.14–0.56)




dStudies that included only never-smokers
eEnvironmental tobacco smoking
fSmoking risk levels: I, other-light smokers; II, duration ≥30 years and amount ≥10 cigarettes/day; III, duration ≥ 40 years and amount ≥ 20 cigarettes/day
gEversmoker
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Conclusions
Although some reports failed to show indoor radon as a
lung cancer risk, radon is an obvious cause of lung can-
cer if we consider previous studies and scientific evi-
dence. The relatively low radon exposures in houses and
low incidence of lung cancer in the general population,
as well as the strong carcinogenic effects of smoking and
other environmental materials, make estimating the real
risk of indoor radon on lung cancer difficult in epi-
demiological studies.
To overcome the limitations of epidemiological studies,
case–control studies will be essential. To conduct a case–
control study successfully, appropriate study design is very
important. Large samples will be required to detect differ-
ences between cases and controls and enable precise esti-
mations of the effect of radon on lung cancer risk.
Controls should be as similar as possible in terms of age,
sex, social/economic status, area of residence, and housing
type to their matched lung cancer cases. To minimize the
effect of smoking, studies in never-smokers are very im-
portant. Case–control studies on never-smokers could be
conducted to evaluate the synergistic effect of environ-
mental tobacco smoking and indoor radon on lung cancer
risk. However, studies including both smokers and never-
smokers are also required to evaluate the interactions be-
tween radon and smoking for smoking-related lung
cancer. Comprehensive face-to-face interviews are needed
to exclude the influence of inaccurate data by proxy inter-
views. Exact estimations of indoor radon exposure are also
required. To get wider ranges of radon exposure and to
evaluate the dose–response relation between indoor radon
and lung cancer risk more accurately, the study area should
be a radon-prone area rather than an area with lower radon
exposure. Further studies also need to evaluate the different
effects of radon on histologic subtypes of lung cancer.
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